Windows

 

Welcome & Opening Remarks
Rebecca Chopp, President of Colgate University

 


Windows

 


Keynote address -
“Frontiers of Neurotherapeutics”
Dr. Gerald D. Fischbach ‘60
Executive Vice President for Health and Biomedical Sciences and Dean of the Faculty of Medicine, Columbia University

 


Windows

 


“The Business of Biotechnology”

G. Kirk Raab ’59, Chairman, Connetics Corporation

 


Windows

 


"Whither Big Pharma: Niche Opportunities for Drug Discovery."

Jonah Shacknai ’78, Founder and CEO, Medicis Pharmaceutical Corporation

 


Windows

 


          “Modern Drug Discovery:  Convergence of Biology, Chemistry and Physics”

Dr. Harvey J. Berger ’72, Founder, Chairman and CEO,
ARIAD Pharmaceuticals, Inc.

 


Windows

 


"Molecular genetic approaches to obesity and diabetes"

Dr. Rudolph L. Leibel ’63, Professor of Pediatrics and Medicine,
Columbia University

 


Windows

 


“The Future of Health Care in a Networked World”

Dr. Jay H. Sanders ’59, President and CEO, The Global Telemedicine Group

 


Windows

 

Q&A: Question on trends in obesity

 


Windows

 

Q&A: Question on pricing and public perception of the pharmaceuticals industry

 


Windows

 

Q&A: Question on advances in brain pharmacology

 


Windows

 

Q&A: Question on the cost of bringing a new drug to market

 


Windows

 

Q&A: Question on pharmaceutical regulation in the U.S. and Canada

 


Windows
 

Closing Remarks by Dr. Fischbach